SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 145 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,332 | +2.4% | 11,111 | +47.6% | 0.01% | 0.0% |
| Q2 2023 | $157,603 | +235128.4% | 7,530 | +138.6% | 0.01% | +150.0% |
| Q1 2023 | $67 | -46.8% | 3,156 | -36.2% | 0.00% | -60.0% |
| Q4 2022 | $126 | -99.9% | 4,947 | -31.6% | 0.01% | +66.7% |
| Q3 2022 | $174,000 | +56.8% | 7,235 | +25.9% | 0.00% | +50.0% |
| Q2 2022 | $111,000 | +177.5% | 5,745 | +148.6% | 0.00% | – |
| Q1 2022 | $40,000 | -74.2% | 2,311 | -67.4% | 0.00% | -100.0% |
| Q4 2021 | $155,000 | +64.9% | 7,093 | +44.7% | 0.00% | +50.0% |
| Q3 2021 | $94,000 | -6.0% | 4,901 | -15.6% | 0.00% | -33.3% |
| Q2 2021 | $100,000 | +233.3% | 5,808 | +333.1% | 0.00% | +200.0% |
| Q1 2021 | $30,000 | +25.0% | 1,341 | +22.5% | 0.00% | 0.0% |
| Q4 2020 | $24,000 | -90.5% | 1,095 | -93.6% | 0.00% | -66.7% |
| Q3 2020 | $252,000 | +327.1% | 17,044 | +328.2% | 0.00% | +50.0% |
| Q2 2020 | $59,000 | +883.3% | 3,980 | +432.1% | 0.00% | – |
| Q3 2019 | $6,000 | -33.3% | 748 | -23.4% | 0.00% | -100.0% |
| Q2 2019 | $9,000 | -69.0% | 977 | -82.1% | 0.00% | -50.0% |
| Q1 2019 | $29,000 | +45.0% | 5,463 | +21.0% | 0.00% | +100.0% |
| Q4 2018 | $20,000 | +53.8% | 4,515 | +150.3% | 0.00% | 0.0% |
| Q2 2018 | $13,000 | -62.9% | 1,804 | -39.1% | 0.00% | -66.7% |
| Q3 2017 | $35,000 | +34.6% | 2,961 | -16.5% | 0.00% | 0.0% |
| Q4 2016 | $26,000 | +1200.0% | 3,547 | +1302.0% | 0.00% | – |
| Q2 2016 | $2,000 | -81.8% | 253 | -70.7% | 0.00% | -100.0% |
| Q1 2016 | $11,000 | – | 863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |